Physician profile
David Bernal
NPI 1023064243
$366.03
in general payments reported to CMS, 2019-2025
9 companies · $78.35 in 2025
The $78.35 reported for 2025 was less than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2021: $55.25 · 2022: $29.55 · 2025: $78.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $78.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $78.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Portola Pharmaceuticals, LLC | $124.99 | 2019 | |
| Boston Scientific Corporation | $54.33 | 2019 | |
| Pfizer INC. | $43.98 | 2019-2021 | |
| Exact Sciences Corporation | $30.17 | 2025 | Cologuard Collection Kit |
| Abbvie INC. | $29.55 | 2022 | |
| Shield Therapeutics INC | $25.28 | 2025 | |
| Glaxosmithkline, LLC. | $22.90 | 2025 | Arexvy, Shingrix |
| Novartis Pharmaceuticals Corporation | $22.19 | 2021 | |
| Dexcom, INC. | $12.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bernal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.